Supriya Pokkali Selected Research

Supriya Pokkali Research Topics

11	Tuberculosis (Tuberculoses) 01/2020 - 04/2009
9	Infections 01/2020 - 03/2008
3	Neoplasms (Cancer) 12/2023 - 06/2011
3	Pulmonary Tuberculosis 01/2020 - 02/2009
2	Virus Diseases (Viral Diseases) 12/2023 - 06/2011
2	Granuloma 01/2018 - 01/2015
2	Inflammation (Inflammations) 01/2017 - 10/2014
2	Myositis (Idiopathic Inflammatory Myopathies) 01/2017 - 10/2014
2	Meningeal Tuberculosis (Tuberculous Meningitis) 12/2016 - 01/2013
2	Coinfection 10/2014 - 06/2011
2	Pleural Tuberculosis 04/2009 - 03/2008
1	Calcinosis 10/2015
1	Bites and Stings (Sting) 04/2015
1	Pneumonia (Pneumonitis) 10/2014
1	Klebsiella Infections (Klebsiella Infection) 10/2014
1	Sepsis (Septicemia) 06/2011
1	Pleurisy (Pleuritis) 12/2008

4	ChemokinesIBA 06/2011 - 03/2008
3	VaccinesIBA 01/2020 - 01/2013
3	Matrix Metalloproteinases (MMPs)IBA 01/2019 - 01/2016
3	Chemokine ReceptorsIBA 04/2009 - 03/2008
3	CytokinesIBA 02/2009 - 03/2008
2	AerosolsIBA 01/2018 - 01/2016
2	InterferonsIBA 04/2015 - 12/2008
1	Toll-Like Receptor AgonistsIBA 12/2023
1	BCG Vaccine FDA Link 01/2020
1	Matrix Metalloproteinase InhibitorsIBA 01/2019
1	tasquinimodIBA 01/2019
1	Pyrazinamide FDA LinkGeneric 01/2018
1	Isoniazid (Ftivazide)FDA LinkGeneric 01/2018
1	Etanercept (Enbrel)FDA Link 01/2018
1	AntibodiesIBA 01/2018
1	ZincIBA 01/2018
1	Peptide Hydrolases (Proteases)FDA Link 01/2018
1	Rifampin (Rifampicin)FDA LinkGeneric 01/2018
1	denileukin diftitox (Ontak)FDA Link 01/2017
1	FluorineIBA 01/2017
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2016
1	FluoridesIBA 10/2015
1	SodiumIBA 10/2015
1	cyclic diadenosine phosphateIBA 04/2015
1	Interferon Regulatory FactorsIBA 04/2015
1	N,N- diethyl- 2- (2- (4- methoxyphenyl)- 5,7- dimethyl- pyrazolo(1,5- a)pyrimidin- 3- yl)- acetamideIBA 01/2015
1	Biomarkers (Surrogate Marker)IBA 01/2015
1	2-deoxy-2-fluorosorbitolIBA 10/2014
1	Immune Sera (Antisera)IBA 01/2013
1	Virulence Factors (Pathogenicity Factors)IBA 01/2013
1	Protein Subunits (Protein Subunit)IBA 01/2013
1	LipopolysaccharidesIBA 06/2011
1	HLA-DR Antigens (HLA-DR)IBA 04/2009
1	ImmunosorbentsIBA 02/2009
1	EnzymesIBA 02/2009
1	Fas Ligand Protein (Fas Ligand)IBA 12/2008

2	Immunotherapy 12/2023 - 01/2017
2	Therapeutics 01/2017 - 12/2016
1	Intravenous Administration 01/2020
1	Aftercare (After-Treatment) 01/2016
1	Drug Therapy (Chemotherapy) 10/2014